Cancer Immunotherapy: New Pathways and Innovating Therapeutics

Jan 17–20, 2028 | Keystone Resort, Keystone, CO, United States
Scientific Organizers: Niroshana Anandasabapathy, Charles G. Drake, and Yardena Samuels

  Livestream
  In Person
  On Demand
×

-

Jan 17–20, 2028 | Keystone Resort, Keystone, CO, United States

Scientific Organizers: Niroshana Anandasabapathy, Charles G. Drake, and Yardena Samuels

Supported by:  

***Meeting program subject to change.

Available Formats:     = Livestream   = In Person     = On Demand
Monday, January 17, 2028
Registration
4:00–8:00 PM
Welcome Mixer
6:00–8:00 PM
Tuesday, January 18, 2028
Breakfast
7:00–8:00 AM
Welcome Remarks
8:00–8:10 AM
Keynote Address
8:10–9:00 AM
Fred J. Ramsdell †, Sonoma Biotherapeutics
Why I Won the Nobel Prize, and the Relevance to Cancer Immunotherapy
Frankensteining the Future: Transformative Technologies, Next Generation Screens, and AI-based Responses
9:00–11:15 AM
Benjamin Izar †, Columbia Universtiy Medical Center
Base Editing Screens Advancing IO
Aviv Regev †, Genentech
The future of IO
Ashley Lakner †, Roche
Directing Early-Stage Discovery Pipelines Focused on Novel Cancer Immunotherapies
Short Talk(s) Chosen from Abstracts
Coffee Break
9:30–9:50 AM
Panel Discussion and Debate 1: Spectacular Failures and what we Learned: Why have Checkpoints Failed Beyond PD1; CAR Failures and what was Learned
11:25–12:25 PM
Poster Setup
12:25–1:30 PM
On Own for Lunch
12:25–5:00 PM
Poster Viewing
1:30–10:00 PM
Symposia Spotlight 1: Novel Antigen Targets for ADC and T Cell Engager
2:30–4:30 PM
Short Talks Chosen from Abstracts
Coffee Available
4:30–5:00 PM
New Antigen Spaces, Immune Editing, and the Bystander Crowd
5:00–7:00 PM
Yardena Samuels, Weizmann Institute of Science
Challenges and Solutions in Effectively Targeting Neoantigens
Evan W. Newell, Fred Hutchinson Cancer Research Center
The Bystander Effect, Viral Responses Shaping Tumor Immunity
Özlem Türeci †, BioNTech
Transformative Vaccine Strategies for Cancer Care
Short Talk(s) Chosen from Abstracts
Social Hour with Dinner
7:00–8:00 PM
Posters
7:30–10:00 PM
Wednesday, January 19, 2028
Breakfast
7:00–8:00 AM
Spectacular Wins and Failures in IO: Lessons Learned and Alternative Paths
8:00–11:00 AM
Saar I. Gill, University of Pennsylvania
Balancing Failures with New Directions: What Works and Why?
Jennifer Ann Wargo †, University of Texas MD Anderson Cancer Center
Microbiome and Cancer: The Bumpy Road to Success
Jedd D. Wolchok †, Weill Cornell Medicine
The Bermuda Triangle of IO: TIGIT, IDO, LAG3
Yvonne Y. Chen, University of California, Los Angeles
Biomolecular Engineering and Synthetic Biology Approaches to Enhance CARs
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
Poster Setup
11:00–1:00 PM
On Own for Lunch
11:00–5:00 PM
Poster Viewing
1:00–10:00 PM
Career Roundtable
3:00–4:30 PM
Coffee Available
4:30–5:00 PM
IO DJs: Modulating Innate and Adaptive Immune Circuits
5:00–7:00 PM
Ana Carrizosa Anderson, Harvard Medical School
Emerging T Cell Targets from Basic Discovery
Andrea Schietinger, Memorial Sloan Kettering Cancer Center
Tumor Immune Triads
Paul G. Thomas, Fred Hutchinson Cancer Center
What Really Dictates Successful Immunity to Flu and Cancer
Thorsten R. Mempel, Massachusetts General Hospital
Chemokines Organizing Anti-Tumor Immunity
Short Talk(s) Chosen from Abstracts
Social Hour with Dinner
7:00–8:00 PM
Posters
7:30–10:00 PM
Thursday, January 20, 2028
Breakfast
7:00–8:00 AM
Translating Myeloid Biology to New Targets, and Alternatives
8:00–11:00 AM
David Sancho, Centro Nacional de Investigaciones Cardiovasculares, CNIC
Targeting Dendritic Cells in Cancer Immunotherapy
Speaker to be Announced
Niroshana Anandasabapathy, Weill Cornell Medicine
Drivers of Immune Related Adverse Events: A Failure in IO or a Spectacular Success?
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
Panel Discussion and Debate 2: Suboptimal Priming vs. Hostile TME. TAA/Neoantigen/Bystander: What Really Matters and Why?
11:10–12:10 PM
On Own for Lunch
12:10–5:00 PM
Symposia Spotlight 2: Tumor Immune Resistance
2:30–4:30 PM
Short Talks Chosen from Abstracts
Coffee Available
4:30–5:00 PM
Immune Set Points in Cancer
5:00–6:45 PM
Charles G. Drake, Johnson and Johnson
T Cell Engagers: An Evolving IO Approach for Solid Tumors
Kole T. Roybal †, University of California, San Francisco
Cellular Engineering, Translation, and Paving the Way to Industry
Haydn Kissick, Emory University
Setpoints Driving TCF7, Immune Memory, and Successful IO Responses
Short Talk(s) Chosen from Abstracts
Meeting Wrap-Up: Outcomes and Future Directions
6:45–7:00 PM
Social Hour with Dinner
7:00–8:00 PM
Entertainment
8:00–11:00 PM
Cash Bar
8:00–11:00 PM
Friday, January 21, 2028
Departure
12:00–11:59 PM

Subscribe for Updates